{"mainPropery":{"diseaseId":10430,"diseaseName":"Dravet syndrome","hasGardWebPage":true,"isRare":true,"websiteUrl":"https://rarediseases.info.nih.gov/diseases/10430/dravet-syndrome","synonyms":["Severe Myoclonic Epilepsy of Infancy","SMEI","Myoclonic epilepsy, severe, of infancy","SME"],"synonyms-with-source":[{"name":"Severe Myoclonic Epilepsy of Infancy"},{"name":"SMEI"},{"name":"Myoclonic epilepsy, severe, of infancy"},{"name":"SME"}],"identifiers":[{"identifierType":"OMIM","identifierId":"607208"},{"identifierType":"ORPHANET","identifierId":"33069"},{"identifierType":"UMLS","identifierId":"C0751122"}]},"diseaseCategories":[{"diseaseTypeId":5,"diseaseTypeName":"Congenital and Genetic Diseases","source":"Orphanet"},{"diseaseTypeId":17,"diseaseTypeName":"Nervous System Diseases","source":"Orphanet"}],"organizations":[{"resourceID":413,"resourceName":"Epilepsy Foundation","abbreviation":"","address1":"8301 Professional Place East","address2":"Suite 230","address3":"","address4":"","address5":"","city":"Landover","state":"MD","zip":"20785","country":"United States","phone":"+1-301-459-3700 ","tty":"","tollFree":"800-332-1000 (24/7 Helpline)","fax":"+1-301-577-2684","email":"contactus@efa.org","url":"https://www.epilepsy.com/","freeText":"en Espa√±ol 1-866-748-8008"},{"resourceID":2265,"resourceName":"Dravet Syndrome Foundation, Inc","abbreviation":"DSF","address1":"PO Box 16536","address2":"","address3":"","address4":"","address5":"","city":"West Haven","state":"CT","zip":"06516","country":"","phone":"+1-203-392-1950","tty":"","tollFree":"","fax":"+1-203-907-1940","email":"info@dravetfoundation.org","url":"http://www.dravetfoundation.org/","freeText":""},{"resourceID":2158,"resourceName":"Genetic Testing Registry","abbreviation":"GTR","address1":"","address2":"","address3":"","address4":"","address5":"","city":"","state":"","zip":"","country":"","phone":"","tty":"","tollFree":"","fax":"","email":"","url":"https://www.ncbi.nlm.nih.gov/gtr/","freeText":""}],"resource descriptions":[{"id":7,"resourceId":10,"resourceName":"Online Mendelian Inheritance in Man (OMIM)","descriptionText":"<a href='http://www.omim.org/607208' target='_blank'>Online Mendelian Inheritance in Man (OMIM)</a> is a catalog of human genes and genetic disorders. Each entry has a summary of related medical articles. It is meant for health care professionals and researchers. OMIM is maintained by Johns Hopkins University School of Medicine.&nbsp;<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":8,"resourceId":11,"resourceName":"PubMed","descriptionText":"<a href='http://www.ncbi.nlm.nih.gov/sites/entrez?itool=omim_Detailed&DbFrom=omim&Cmd=Link&LinkName=omim_pubmed_calculated&IdsFromResult=607208' target='_blank'>PubMed</a> is a searchable database of medical literature and lists journal articles that discuss Dravet syndrome. Click on the link to view a sample search on this topic.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":9,"resourceId":12,"resourceName":"ClinicalTrials.gov","descriptionText":"<a href='http://clinicaltrials.gov/ct2/results?term=dravet+syndrome' target='_blank'>ClinicalTrials.gov</a> lists trials that are related to Dravet syndrome. Click on the link to go to ClinicalTrials.gov to read descriptions of these studies. <br />\r\n<br />\r\n<em><strong>Please note:</strong>&nbsp;Studies listed on the&nbsp;ClinicalTrials.gov&nbsp;website are listed for informational purposes only; being listed does not reflect an endorsement by GARD or the NIH. We strongly recommend that you talk with a trusted healthcare provider before choosing to participate in any clinical study.</em>","resourceClassificationName":"Research","resourceClassificationSectionName":"Clinical Research Resources"},{"id":336,"resourceId":1154,"resourceName":"RareConnect","descriptionText":"<div style=\"margin-top: 0px; margin-bottom: 0px;\"><a href='https://www.rareconnect.org/en/community/dravet-syndrome' target='_blank'>RareConnect</a> has an online community for patients&nbsp;and families with this condition so they can connect with others and share&nbsp;their experiences living with a rare disease.&nbsp;The project is a joint collaboration between EURORDIS (European Rare Disease Organisation) and NORD (National Organization for Rare Disorders).</div>","resourceClassificationName":"Organizations","resourceClassificationSectionName":"Social Networking Websites"},{"id":1457,"resourceId":2104,"resourceName":"Genetic Services","descriptionText":"To find a medical professional who specializes in genetics, you can ask your doctor for a referral or you can search for one yourself. Online directories are provided by the <a href='http://www.acmg.net/ACMG/Genetic_Services_Directory_Search.aspx' target='_blank'>American College of Medical Genetics</a> and the&nbsp;<a href='https://www.findageneticcounselor.com/' target='_blank'>National Society of Genetic Counselors</a>. If you need additional help, <a href=\"https://rarediseases.info.nih.gov/about-gard/contact-gard\">contact a GARD Information Specialist</a>. You can also&nbsp;<a href='https://ghr.nlm.nih.gov/primer#consult' target='_blank'>learn more about genetic consultations</a>&nbsp;from Genetics Home Reference.","resourceClassificationName":"Find a Specialist","resourceClassificationSectionName":"Healthcare Resources"},{"id":1527,"resourceId":2159,"resourceName":"National Organization for Rare Disorders","descriptionText":"The <a href='https://rarediseases.org/rare-diseases/dravet-syndrome-spectrum/' target='_blank'>National Organization for Rare Disorders</a> (NORD) has a report for patients and families about this condition. NORD is a patient advocacy organization for individuals with rare diseases and the organizations that serve them.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":1530,"resourceId":2161,"resourceName":"National Institute of Neurological Disorders and Stroke (NINDS)","descriptionText":"The <a href='https://www.ninds.nih.gov/Disorders/All-Disorders/Dravet-Syndrome-Information-Page' target='_blank'>National Institute of Neurological Disorders and Stroke</a> (NINDS) collects and disseminates research information related to neurological disorders. Click on the link to view information on&nbsp;this topic.","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":1532,"resourceId":2163,"resourceName":"Social Security Administration","descriptionText":"The <a href='https://secure.ssa.gov/apps10/poms.nsf/lnx/0423022943' target='_blank'>Social Security Administration</a> has included this condition in their Compassionate Allowances Initiative. This initiative speeds up the processing of disability claims for applicants with certain medical conditions that cause severe disability. More information about <a href=\"http://www.ssa.gov/compassionateallowances/index.htm\" target=\"_blank\">Compassionate Allowances</a> and <a href=\"https://www.ssa.gov/benefits/disability/\" target=\"_blank\">applying for Social Security disability</a> is available online.","resourceClassificationName":"Living With","resourceClassificationSectionName":"Financial Resources"},{"id":1534,"resourceId":2165,"resourceName":"Orphanet","descriptionText":"<a href='http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&Expert=33069' target='_blank'>Orphanet</a> is a European reference portal for&nbsp;information on rare diseases and orphan drugs. Access to this database is free of charge.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":1537,"resourceId":2168,"resourceName":"GeneReviews","descriptionText":"<a href='https://www.ncbi.nlm.nih.gov/books/NBK1318' target='_blank'>GeneReviews</a> provides current, expert-authored, peer-reviewed, full-text articles describing the application of genetic testing to the diagnosis, management, and genetic counseling of patients with specific inherited conditions.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":1539,"resourceId":2165,"resourceName":"Orphanet","descriptionText":"<a href='http://www.orpha.net/consor/cgi-bin/ResearchTrials_ResearchProjects_Simple.php?lng=EN&LnkId=10307&Typ=Pat' target='_blank'>Orphanet</a> lists European clinical trials, research studies, and patient registries enrolling people with this condition.&nbsp;","resourceClassificationName":"Research","resourceClassificationSectionName":"Clinical Research Resources"},{"id":1541,"resourceId":2165,"resourceName":"Orphanet","descriptionText":"<a href='http://www.orpha.net/consor/cgi-bin/ClinicalLabs_Search_Simple.php?lng=EN&LnkId=10307&Typ=Pat' target='_blank'>Orphanet</a> lists international laboratories offering diagnostic testing for this condition.","resourceClassificationName":"Diagnosis","resourceClassificationSectionName":"Testing Resources"},{"id":1702,"resourceId":2165,"resourceName":"Orphanet","descriptionText":"<a href='https://www.orpha.net/data/patho/Pro/en/Emergency_Dravet.pdf' target='_blank'>Orphanet Emergency Guidelines</a> is an article which is expert-authored and peer-reviewed that is intended to guide health care professionals in emergency situations involving this condition. &nbsp;","resourceClassificationName":"Treatment","resourceClassificationSectionName":"Management Guidelines"},{"id":2135,"resourceId":3342,"resourceName":"Monarch Initiative","descriptionText":"The <a href='https://monarchinitiative.org/disease/OMIM:607208' target='_blank'>Monarch Initiative</a> brings together data about this condition from humans and other species to help physicians and biomedical researchers. Monarch&rsquo;s tools are designed to make it easier to compare the signs and symptoms (phenotypes) of different diseases and discover common features. This initiative is a collaboration between several academic institutions across the world and is funded by the National Institutes of Health. Visit the website to explore the biology of this condition.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":2337,"resourceId":2265,"resourceName":"Dravet Syndrome Foundation, Inc","descriptionText":"The <a href='https://www.dravetfoundation.org' target='_blank'>Dravet Syndrome Foundation, Inc</a>, a non-profit organization, offers information and support resources for&nbsp;Dravet syndrome","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":2722,"resourceId":4053,"resourceName":"Patient Registry","descriptionText":"A registry supports research by collecting of information about patients that share something in common, such as being diagnosed with Dravet syndrome. The type of data collected can vary from registry to registry and is based on the goals and purpose of that registry. Some registries collect contact information while others collect more detailed medical information. <a href=\"https://www.nih.gov/health-information/nih-clinical-research-trials-you/list-registries\" target=\"_blank\">Learn more about registries</a>.<br />\r\n<br />\r\nRegistries for&nbsp;Dravet syndrome:<br />\r\n<a href='https://sites.google.com/umich.edu/iicepr' target='_blank'>International Ion Channel Epilepsy Patient Registry</a><br />&nbsp;","resourceClassificationName":"Research","resourceClassificationSectionName":"Patient Registry"}],"overviewQuestion":{"questionId":2862,"questionText":"What is Dravet syndrome?","answerText":"<strong>Dravet syndrome&nbsp;</strong>is the most severe of a group of conditions known as <em><a href=\"https://rarediseases.info.nih.gov/diseases/12996/scn1a-related-seizure-disorders\" target=\"_blank\">SCN1A-</a></em><a href=\"https://rarediseases.info.nih.gov/diseases/12996/scn1a-related-seizure-disorders\" target=\"_blank\">related seizure disorders</a>. Symptoms include seizures which first occur in infancy that are often triggered by high temperatures (<a href=\"https://www.ninds.nih.gov/Disorders/Patient-Caregiver-Education/Fact-Sheets/Febrile-Seizures-Fact-Sheet\" target=\"_blank\">febrile seizures</a>). In childhood, many types of seizures may occur and they may increase in frequency. Seizures may be difficult to treat.&nbsp;Other symptoms include loss of motor skills, intellectual disability, speech impairment, and difficulty with movement. Most cases of Dravet syndrome occur when the&nbsp;<a href=\"http://ghr.nlm.nih.gov/gene/SCN1A\" target=\"_blank\"><em>SCN1A</em></a>&nbsp;gene is not working correctly. It can be inherited in an autosomal dominant pattern, but most people with Dravet syndrome do not have a family history of the condition. Diagnosis is based on a clinical exam, medical history, and the results of genetic testing. The main goal of treatment is to reduce the number and length of seizures.[15701][15702][15703]","dateModified":"2020-07-06T00:00:00"},"basicQuestions":[{"questionId":13556,"questionText":"What are the signs and symptoms of Dravet syndrome?&nbsp;","answerText":"The following list includes the most common signs and symptoms in people with Dravet syndrome. These features may be different from person to person. Some people may have more symptoms than others and symptoms can range from mild to severe. This list does not include every symptom or feature that has been described in this condition.<br />\r\n<br />\r\nSigns and symptoms include:&nbsp;<br />\r\n<ul>\r\n    <li>Many different types of <a href=\"https://medlineplus.gov/seizures.html\" target=\"_blank\">seizures</a></li>\r\n    <li>Sudden muscle jerking (<a href=\"https://www.ninds.nih.gov/Disorders/Patient-Caregiver-Education/Fact-Sheets/Myoclonus-Fact-Sheet\" target=\"_blank\">myoclonus</a>)</li>\r\n    <li>Loss of developmental skills</li>\r\n    <li>Intellectual disability</li>\r\n    <li>Problems with walking</li>\r\n    <li>Speech impairment</li>\r\n    <li>Autistic-like behavior</li>\r\n</ul>\r\nThe first seizures appear before one year of age and are often associated with fevers. In childhood, other types of seizures develop, and the frequency of seizures increases. Loss of developmental and cognitive skills may occur along with speech impairment and difficulty walking. In adulthood, the number of seizures may decrease, and nighttime seizures may occur. More serious complications include the risk of continuous seizures (<a href=\"https://www.ninds.nih.gov/Disorders/Patient-Caregiver-Education/Hope-Through-Research/Epilepsies-and-Seizures-Hope-Through#3109_19\" target=\"_blank\">status epilepticus</a>) and sudden unexplained death.[15701][15702][11373]","dateModified":"2020-07-06T14:55:00","resourceClassificationName":"Symptoms","references":[{"referenceId":11373,"authors":"Miller IO & Sotero de Menezes MA","articleTitle":"SCN1A-Related Seizure Disorders","bookWebsiteJournalTitle":"GeneReviews","date":"May, 2014","volume":"","pages":"","url":"http://www.ncbi.nlm.nih.gov/books/NBK1318/","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":15701,"authors":"Lagae L, Brambilla I, Mingorance A, Gibson E, Battersby A","articleTitle":"Quality of life and comorbidities associated with Dravet syndrome severity: a multinational cohort survey","bookWebsiteJournalTitle":"Dev Med Child Neurol","date":"2018","volume":"60(1)","pages":"63-72","url":"https://pubmed.ncbi.nlm.nih.gov/28984349","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":15702,"authors":"Gataullina S, Dlac O","articleTitle":"From genotype to phenotype in Dravet disease","bookWebsiteJournalTitle":"Seizure","date":"2017","volume":"44","pages":"58-64","url":"https://pubmed.ncbi.nlm.nih.gov/27817982","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":13558,"questionText":"How is Dravet syndrome inherited?","answerText":"In some cases, Dravet syndrome is inherited in an autosomal dominant pattern.[11373] All individuals inherit two copies of each gene. Autosomal means the gene is found on one of the numbered chromosomes found in both sexes. Dominant means that only one altered copy of a gene is necessary to have the condition. The alteration can be inherited from either parent. Dravet syndrome usually occurs due to a new genetic change that occurs for the first time in a person and is not present in either parent (de novo mutation).<br />\r\n&nbsp;&nbsp;<br />\r\nEach child of an individual with an autosomal dominant condition has a 50% or 1 in 2 chance of inheriting the alteration and the condition. Typically, children who inherit a dominant alteration will have the condition, but they may be more or less severely affected than their parent. Sometimes a person may have a gene alteration for an autosomal dominant condition and show no signs or symptoms of the condition.<br />","dateModified":"2020-07-06T15:25:00","resourceClassificationName":"Inheritance","references":[{"referenceId":11373,"authors":"Miller IO & Sotero de Menezes MA","articleTitle":"SCN1A-Related Seizure Disorders","bookWebsiteJournalTitle":"GeneReviews","date":"May, 2014","volume":"","pages":"","url":"http://www.ncbi.nlm.nih.gov/books/NBK1318/","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":13559,"questionText":"How is Dravet syndrome diagnosed?","answerText":"Dravet syndrome is diagnosed based on the results of a clinical exam looking for specific symptoms that have been previously seen in this condition.[15699] Genetic testing can also be helpful.[15702]<br />\r\n<br />\r\nDiagnosis is important because certain anti-seizure medications (sodium-channel agents) can make the seizures worse in Dravet syndrome.[15702]","dateModified":"2020-07-06T15:28:00","resourceClassificationName":"Diagnosis","references":[{"referenceId":15699,"authors":"Wirrell EC, Laux L, Donner E, et al.","articleTitle":"Optimizing the Diagnosis and Management of Dravet Syndrome: Recommendations From a North American Consensus Panel.","bookWebsiteJournalTitle":"Pediatr Neurol. 2017;68:18-34.e3.","date":"2017","volume":"68","pages":"18-34.e.3","url":"https://pubmed.ncbi.nlm.nih.gov/28284397","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":15702,"authors":"Gataullina S, Dlac O","articleTitle":"From genotype to phenotype in Dravet disease","bookWebsiteJournalTitle":"Seizure","date":"2017","volume":"44","pages":"58-64","url":"https://pubmed.ncbi.nlm.nih.gov/27817982","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":13560,"questionText":"How might Dravet syndrome be treated?","answerText":"Treatment for Dravet syndrome is focused on reducing the number and length of seizures. The seizures seen with Dravet syndrome are usually difficult to control, and people with this condition often need to take multiple anti-seizure medications. Certain types of anti-seizure medications (sodium-channel agents) can make the seizures worse and should be avoided. New medications are being tested that are proven to be helpful in this condition.[15702][15703]&nbsp;<br />\r\n<br />\r\nSpecialists who may be involved in the care of someone with Dravet syndrome include:<br />\r\n<ul>\r\n    <li>Neurologist</li>\r\n    <li>Developmental pediatrician</li>\r\n    <li>Physical therapist</li>\r\n    <li>Occupational therapist</li>\r\n    <li>Speech therapist</li>\r\n</ul>","dateModified":"2020-07-06T15:37:00","resourceClassificationName":"Treatment","references":[{"referenceId":15702,"authors":"Gataullina S, Dlac O","articleTitle":"From genotype to phenotype in Dravet disease","bookWebsiteJournalTitle":"Seizure","date":"2017","volume":"44","pages":"58-64","url":"https://pubmed.ncbi.nlm.nih.gov/27817982","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":15703,"authors":"Knupp KG, Wirrell EC","articleTitle":"Treatment Strategies for Dravet Syndrome [published correction appears in CNS Drugs. 2018 Aug;32(8):783. Abstract corrected].","bookWebsiteJournalTitle":"CNS Drugs","date":"2018","volume":"32(4)","pages":"335-350","url":"https://pubmed.ncbi.nlm.nih.gov/29594870","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":13561,"questionText":"How many people have Dravet syndrome?","answerText":"It is estimated that 1 in 15,700 to 1 in 40,000 people has Dravet syndrome.[15700] The exact number of people with this condition is unknown.","dateModified":"2020-07-06T15:41:00","resourceClassificationName":"Statistics","references":[{"referenceId":15700,"authors":"Wu YW, Sullivan J, McDaniel SS, et al","articleTitle":"Incidence of Dravet Syndrome in a US Population","bookWebsiteJournalTitle":"Pediatrics","date":"2015","volume":"136(5)","pages":"e1310-1315","url":"https://pubmed.ncbi.nlm.nih.gov/26438699","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":13557,"questionText":"What is the cause of Dravet syndrome?","answerText":"Dravet syndrome occurs when the <em><a href=\"https://ghr.nlm.nih.gov/gene/SCN1A\" target=\"_blank\">SCN1A</a></em> gene is not working correctly.&nbsp;DNA changes known as <a href=\"https://www.cancer.gov/publications/dictionaries/genetics-dictionary/def/genetic-variant \" target=\"_blank\">pathogenic variants</a> are responsible for making genes work incorrectly or sometimes, not at all.[15702]&nbsp;<br />\r\n<br />\r\nDNA changes in the <em><a href=\"https://ghr.nlm.nih.gov/gene/SCN1B\" target=\"_blank\">SCN1B</a></em>, <em><a href=\"https://ghr.nlm.nih.gov/gene/GABRG2\" target=\"_blank\">GABRG2</a></em>, <em><a href=\"https://ghr.nlm.nih.gov/gene/SCN2A\" target=\"_blank\">SCN2A</a></em> and several other genes are associated with seizure disorders with similar symptoms to Dravet syndrome.[15703]&nbsp;","dateModified":"2020-07-06T15:16:00","resourceClassificationName":"Cause","references":[{"referenceId":15702,"authors":"Gataullina S, Dlac O","articleTitle":"From genotype to phenotype in Dravet disease","bookWebsiteJournalTitle":"Seizure","date":"2017","volume":"44","pages":"58-64","url":"https://pubmed.ncbi.nlm.nih.gov/27817982","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":15703,"authors":"Knupp KG, Wirrell EC","articleTitle":"Treatment Strategies for Dravet Syndrome [published correction appears in CNS Drugs. 2018 Aug;32(8):783. Abstract corrected].","bookWebsiteJournalTitle":"CNS Drugs","date":"2018","volume":"32(4)","pages":"335-350","url":"https://pubmed.ncbi.nlm.nih.gov/29594870","authors2":"","placeOfPublication":"","publisher":""}]}],"references":[{"referenceId":1872,"authors":"","articleTitle":"Epileptic encephalopathy, early infantile, 6 (EIEE6)","bookWebsiteJournalTitle":"Online Mendelian Inheritance in Man (OMIM)","date":"Updated 7/9/2016","volume":"","pages":"","url":"http://omim.org/entry/607208","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":15700,"authors":"Wu YW, Sullivan J, McDaniel SS, et al","articleTitle":"Incidence of Dravet Syndrome in a US Population","bookWebsiteJournalTitle":"Pediatrics","date":"2015","volume":"136(5)","pages":"e1310-1315","url":"https://pubmed.ncbi.nlm.nih.gov/26438699","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":15701,"authors":"Lagae L, Brambilla I, Mingorance A, Gibson E, Battersby A","articleTitle":"Quality of life and comorbidities associated with Dravet syndrome severity: a multinational cohort survey","bookWebsiteJournalTitle":"Dev Med Child Neurol","date":"2018","volume":"60(1)","pages":"63-72","url":"https://pubmed.ncbi.nlm.nih.gov/28984349","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":15702,"authors":"Gataullina S, Dlac O","articleTitle":"From genotype to phenotype in Dravet disease","bookWebsiteJournalTitle":"Seizure","date":"2017","volume":"44","pages":"58-64","url":"https://pubmed.ncbi.nlm.nih.gov/27817982","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":15703,"authors":"Knupp KG, Wirrell EC","articleTitle":"Treatment Strategies for Dravet Syndrome [published correction appears in CNS Drugs. 2018 Aug;32(8):783. Abstract corrected].","bookWebsiteJournalTitle":"CNS Drugs","date":"2018","volume":"32(4)","pages":"335-350","url":"https://pubmed.ncbi.nlm.nih.gov/29594870","authors2":"","placeOfPublication":"","publisher":""}],"relatedDiseases":[],"gardCases":[],"news":[{"newsId":671,"dateCreated":"2020-05-20T13:39:00","publishDate":"2020-05-22T00:00:00","title":"NIH-Supported Research Survey to Examine Impact of COVID-19 on Rare Diseases Community","description":"The NIH-funded Rare Diseases Clinical Research Network (RDCRN) has launched an <a href=\"https://www.rarediseasesnetwork.org/COVIDsurvey \" target=\"_blank\">online research survey</a> to find out how the COVID-19 pandemic is impacting individuals with rare diseases, their families and their caregivers. Your participation can help the rare disease research community shed light on the needs of people with rare diseases during this and other potential health crises, in addition to informing future research efforts. The survey must be completed by December 15, 2020.","url":"https://www.rarediseasesnetwork.org/COVIDsurvey","lastModified":"2020-11-30T14:44:00","isFeatured":false}],"conferences":[],"phenoTypes":[{"phenoTypeId":5154,"phenoTypeName":"Developmental regression","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":13630,"phenoTypeName":"Progressive gait ataxia","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":14132,"phenoTypeName":"Anxiety","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":13649,"phenoTypeName":"Atypical absence seizure","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":6021,"phenoTypeName":"Autistic behavior","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":13456,"phenoTypeName":"Bradykinesia","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":11728,"phenoTypeName":"Cognitive impairment","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":5172,"phenoTypeName":"Cogwheel rigidity","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":10631,"phenoTypeName":"Complex febrile seizure","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":8009,"phenoTypeName":"Epilepsia partialis continua","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":2823,"phenoTypeName":"Facial tics","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":11428,"phenoTypeName":"Focal aware seizure","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":12138,"phenoTypeName":"Focal hemiclonic seizure","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":5162,"phenoTypeName":"Focal impaired awareness seizure","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":10623,"phenoTypeName":"Generalized clonic seizure","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":10465,"phenoTypeName":"Limited neck range of motion","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":5110,"phenoTypeName":"Multifocal epileptiform discharges","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":10639,"phenoTypeName":"Myoclonus","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":4686,"phenoTypeName":"Obsessive-compulsive trait","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":9388,"phenoTypeName":"Parkinsonism","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":9416,"phenoTypeName":"Photosensitive myoclonic seizure","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":8518,"phenoTypeName":"Photosensitive tonic-clonic seizure","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":11426,"phenoTypeName":"Action tremor","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":9432,"phenoTypeName":"Cyanotic episode","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":11398,"phenoTypeName":"Drooling","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":5335,"phenoTypeName":"Dysgenesis of the hippocampus","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":14015,"phenoTypeName":"EEG with generalized epileptiform discharges","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":11234,"phenoTypeName":"Global brain atrophy","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":11798,"phenoTypeName":"Impulsivity","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":11393,"phenoTypeName":"Incoordination","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":3425,"phenoTypeName":"Infantile muscular hypotonia","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":10058,"phenoTypeName":"Limited knee extension","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":8266,"phenoTypeName":"Pallor","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":3900,"phenoTypeName":"Pes planus","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":1333,"phenoTypeName":"Pes valgus","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":4479,"phenoTypeName":"Poor fine motor coordination","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":14130,"phenoTypeName":"Short attention span","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":5503,"phenoTypeName":"Status epilepticus without prominent motor symptoms","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":11784,"phenoTypeName":"Tibial torsion","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":11202,"phenoTypeName":"Generalized tonic seizure","frequencyText":"Very rare","percentRanges":"1%-4%"},{"phenoTypeId":8521,"phenoTypeName":"Abnormal pyramidal sign","percentRanges":"-"},{"phenoTypeId":8720,"phenoTypeName":"Ataxia","percentRanges":"-"},{"phenoTypeId":11204,"phenoTypeName":"Atonic seizure","percentRanges":"-"},{"phenoTypeId":6539,"phenoTypeName":"Autosomal dominant inheritance","percentRanges":"-"},{"phenoTypeId":13447,"phenoTypeName":"Cerebral atrophy","percentRanges":"-"},{"phenoTypeId":11795,"phenoTypeName":"Cerebral visual impairment","percentRanges":"-"},{"phenoTypeId":1126,"phenoTypeName":"Epileptic encephalopathy","percentRanges":"-"},{"phenoTypeId":13747,"phenoTypeName":"Generalized myoclonic seizure","percentRanges":"-"},{"phenoTypeId":13746,"phenoTypeName":"Generalized non-motor (absence) seizure","percentRanges":"-"},{"phenoTypeId":8723,"phenoTypeName":"Global developmental delay","percentRanges":"-"},{"phenoTypeId":6245,"phenoTypeName":"Infantile onset","percentRanges":"-"},{"phenoTypeId":8727,"phenoTypeName":"Mental deterioration","percentRanges":"-"},{"phenoTypeId":8729,"phenoTypeName":"Motor delay","percentRanges":"-"},{"phenoTypeId":6870,"phenoTypeName":"Myoclonic seizure","percentRanges":"-"},{"phenoTypeId":9533,"phenoTypeName":"Postnatal microcephaly","percentRanges":"-"},{"phenoTypeId":13751,"phenoTypeName":"Status epilepticus","percentRanges":"-"},{"phenoTypeId":11492,"phenoTypeName":"Visually-induced seizure","percentRanges":"-"}],"medicalProducts":[{"productId":734,"genericName":"Stiripentol","tradeName":"Diacomit","tradeLink":"http://www.diacomit.eu/","manufacturer":"","sponsor":"Biocodex","indication":"August 2018, stiripentol (Diacomit) was approved for the treatment of seizures associated with Dravet syndrome (DS) in patients 2 years of age and older taking clobazam.","drugInformationLink":"https://druginfo.nlm.nih.gov/drugportal/rn/49763-96-4","medlinePlusLink":""},{"productId":726,"genericName":"Cannabidiol","tradeName":"Epidiolex","tradeLink":"https://www.epidiolex.com/","manufacturer":"","sponsor":"GW Pharma Ltd.","indication":"June 2018, cannabidiol (Epidiolex) was approved for the treatment of seizures associated with Lennox-Gastaut syndrome (LGS) or Dravet syndrome (DS) in patients 2 years of age and older. Sept 2018, the DEA (US Drug Enforcement Agency) placed Epidolex in schedule V of Controlled Substance Act. However, availability may be dependent on laws of individual States.","drugInformationLink":"https://druginfo.nlm.nih.gov/drugportal/name/epidiolex","medlinePlusLink":"https://medlineplus.gov/druginfo/natural/1439.html"},{"productId":768,"genericName":"Fenfluramine HCI","tradeName":"Fintepla","tradeLink":"https://www.fintepla.com/","manufacturer":"","sponsor":"Zogenix, Inc","indication":"Fintepla (fenfluramine) is indicated for the treatment of seizures associated with Dravet syndrome in patients 2 years of age and older.","drugInformationLink":"https://druginfo.nlm.nih.gov/drugportal/rn/404-82-0","medlinePlusLink":""}],"EncodedName":"Dravet_syndrome"}